Status:
UNKNOWN
Clinical Performance of Composites in Patients With Amelogenesis Imperfecta
Lead Sponsor:
Neslihan Tekçe
Conditions:
Amelogenesis Imperfecta
Dental Caries
Eligibility:
All Genders
14-30 years
Phase:
NA
Brief Summary
In AI patients, adhesion still remains the first option in order to achieve an early, minimally invasive intervention, and the altered enamel still represents an acceptable substrate for bonding in so...
Eligibility Criteria
Inclusion
- the patient had to require treatment due to carious lesions in one or more surface of molars and premolars,
- AI diagnosis had to be made, which had to be verified clinically, and also confirmed by anamnestic family history, or clinical examination concerning Witkop's classification
Exclusion
- patients with developmental enamel defects of other origins such as fluorosis, molar incisor hypomineralization;
- AI was associated with other oral developmental or systemic disorders, and dental abnormalities such as open-bite, deep-bite, and cross-bite;
- patients who were unable to provide their informed consent.
Key Trial Info
Start Date :
September 2 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04897724
Start Date
September 2 2014
Last Update
May 21 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.